Bioethics, Ltd.
BOTH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.36K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $18,361.00 |
|---|---|
| Enterprise Value | $423,479.00 |
| Earnings per Share | $-0.12 |
| Beta | -6.53 |
| Outstanding Shares | 3,335,194 |
Return
| Return on Equity | 19.00% |
|---|---|
| Return on Assets | -1206.73% |
| Return on Invested Capital | 13.19% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | -0.04 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.45 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | -0.45 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Bioethics, Ltd.
1 employees
CEO: Mark A. Scharmann
Established in 1990 and located in Ogden, Utah, Bioethics, Ltd. is not currently involved in substantial business activities. Instead, the company plans to explore, assess, and, if appropriate, acquire a stake in a new commercial enterprise.